Improving upon nature's somatic mitochondrial DNA therapies

Medical Hypotheses

Volumn 74, Issue 6, 2010, Pages 1021-1025

  Dani, M A ^a   Dani, S U ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Medawar Institute for Medical and Environmental Research   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ARTICLE; CARCINOGENESIS; CELL DIVISION; CELL METABOLISM; CELL PROLIFERATION; CELL RENEWAL; CELL TYPE; CLADOGENESIS; DEVELOPMENTAL STAGE; DNA REPAIR; EMBRYO DEVELOPMENT; EUKARYOTIC CELL; GAMETOGENESIS; GENE MUTATION; GENE THERAPY; GENETIC COMPLEMENTATION; GENETIC POLYMORPHISM; GENETIC STABILITY; HAPLOTYPE; HORIZONTAL GENE TRANSFER; HUMAN; HYPOTHESIS; LONGEVITY; MITOSIS; MUTAGENICITY; NATURAL SELECTION; NONHUMAN; PRIMATE; SPECIES DIFFERENCE; STEM CELL; UPREGULATION;

ANIMALS; DNA, MITOCHONDRIAL; GENE CONVERSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC COMPLEMENTATION TEST; HUMANS; MODELS, GENETIC; MUTATION; STEM CELL TRANSPLANTATION; STEM CELLS;

ANIMALIA; EUKARYOTA; PRIMATES;

EID: 77951622979     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.01.005     Document Type: Article

References (73)

1. Tuppen HA, Blakely EL, Tumbull DM, Taylor RW. Mitochondrial DNA mutations and human disease. Biochim Biophys Acta 2009 Sep 15 [Epub ahead of print].
2. Kukat A., Trifunovic A. Somatic mtDNA mutations and aging - facts and fancies. Exp Gerontol 2009, 44:101-105.
3. Niemi A.K., Hervonen A., Hurme M., Karhunen P.J., Jylhä M., Majama K. Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Hum Genet 2002, 112:29-33.
4. Niemi A.K., Moilanen J.S., Tanaka M., Hervonen A., Hurme M., Lehtimäki T., et al. A combination of three common inherited mitochondrial DNA polymorphisms promotes longevity in Finnish and Japanese subjects. Eur J Hum Genet 2005, 13:166-170.
5. Salvioli S., Capri M., Santoro A., Raule N., Sevini F., Lukas S., et al. Mitochondrial DNA involvement in human longevity. The impact of mitochondrial DNA on human lifespan: a view from studies on centenarians. Biotechnol J 2008, 3:740-749.
6. Cai X.Y., Wang X.F., Li S.L., Qian J., Chen F., Yang Y.J., et al. Association of mitochondrial DNA haplogroups with exceptional longevity in a Chinese population. PLoS One 2009, 4:e6423.
7. Elliot H.R., Samuels D.C., Eden J.A., Relton C.L., Chinnery P.F. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 2008, 83:254-260.
8. Nabholz B., Glémin S., Galtier N. Strong variations of mitochondrial mutation rate across mammals - the longevity hypothesis. Mol Biol Evol 2008, 25:120-130.
9. Irwin J.A., Saunier J.L., Niederstätter H., Strouss K.M., Sturk K.A., Diegoli T.M., et al. Investigation of heteroplasmy in the human mitochondrial DNA control region: a synthesis of observations from more than 5000 global population samples. J Mol Evol 2009, 68:516-527.
10. Soares P., Ermini L., Thomson N., Mormina M., Rito T., Röhl A., et al. Correcting for purifying selection: an improved human mitochondrial molecular clock. Am J Hum Genet 2009, 84:740-759.
11. Dani S.U., Dani M.A., Simpson A.J. The common mitochondrial DNA deletion deltamtDNA(4977): shedding new light to the concept of a tumor suppressor mutation. Med Hypotheses 2003, 61:60-63.
12. Dani M.A., Dani S.U., Lima S.P., Martinez A., Rossi B.M., Soares F., et al. Less deltamtDNA4977 than normal in various types of tumors suggests that cancer cells are essentially free of this mutation. Genet Mol Res 2004, 3:395-409.
13. Galtier N., Jobson R.W., Nabholz B., Glémin S., Blier P.U. Mitochondrial whims: metabolic rate, longevity and the rate of molecular evolution. Biol Lett 2009, 5:413-416.
14. Shen Y.Y., Shi P., Sun Y.B., Zhang Y.P. Relaxation of selective constraints on avian mitochondrial DNA following the degeneration of flight ability. Genome Res 2009, 19:1760-1765.
15. Dani S.U., Simpson A.J.G. Mutation, evolution and aging. Principles of neural aging 1997, 27-33. Elsevier, Amsterdam. S.U. Dani, A. Hori, G.F. Walter (Eds.).
16. Nabholz B., Glémin S., Galtier N. The erratic mitochondrial clock: variations of mutation rate, not population size, affect mtDNA diversity across birds and mammals. BMC Evol Biol 2009, 9:54.
17. Kovalenko S.A., Kopsidas G., Kelso J., Rosenfeldt F., Linnane A.W. Tissue-specific distribution of multiple mitochondrial DNA rearrangements during human aging. Ann N Y Acad Sci 1998, 854:171-181.
18. Meissner C., Bruse P., Oehmichen M. Tissue-specific deletion patterns of the mitochondrial genome with advancing age. Exp Gerontol 2006, 41:518-524.
19. Ono T., Isobe K., Nakada K., Hayashi J.I. Human cells are protected from mitochondrial dysfunction by complementation of DNA products in fused mitochondria. Nat Genet 2001, 28:272-275.
20. Sato A., Nakada K., Hayashi J. Mitochondrial complementation preventing respiratory dysfunction caused by mutant mtDNA. Biofactors 2009, 35:130-137.
21. Menzies R.A., Gold P.H. The turnover of mitochondria in a variety of tissues of young adult and aged rats. J Biol Chem 1971, 246:2425-2429.
22. Pfeifer U. Inhibition by insulin of the formation of autophagic vacuoles in rat liver. A morphometric approach to the kinetics of intracellular degradation by autophagy. J Cell Biol 1978, 78:142-167.
23. Dagda R.K., Zhu J., Kulisch S.M., Chu C.T. Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson's disease. Autophagy 2008, 4:770-782.
24. Rodriguez-Enriquez S., Kim I., Currin R.T., Lemasters J.J. Tracker dyes to probe mitochondrial autophagy (mitophagy) in rat hepatocytes. Autophagy 2006, 2:39-46.
25. Kristensen A.R., Schandorff S., Høyer-Hansen M., Nielsen M.O., Jäättelä M., Dengjel J., et al. Ordered organelle degradation during starvation-induced autophagy. Mol Cell Proteomics 2008, 7:2419-2428.
26. de Grey A.D. A proposed refinement of the mitochondrial free radical theory of aging. BioEssays 1997, 19:161-166.
27. Brunk U.T., Terman A. The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem 2002, 269:1996-2002.
28. Lemasters J.J. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction and aging. Rejuvenation Res 2005, 8:3-5.
29. Howe D.K., Denver D.R. Muller's ratchet and compensatory mutation in Caenorhabditis briggsae mitochondrial genome evolution. BMC Evol Biol 2008, 8:62.
30. Sato A., Nakada K., Akimoto M., Ishikawa K., Ono T., Shitara H., et al. Rare creation of recombinant mtDNA haplotypes in mammalian tissues. Proc Natl Acad Sci USA 2005, 102:6057-6062.
31. Khakhlova O., Bock R. Elimination of deleterious mutations in plastid genomes by gene conversion. Plant J 2006, 46:85-94.
32. Dani S.U. Larger neuronal size overwhelms maintenance capacity with aging. Med Hypotheses 1994, 42:208-210.
33. Storm T., Rath S., Mohamed S.A., Bruse P., Kowald A., Oehmichen M., et al. Mitotic brain cells are just as prone to mitochondrial deletions as neurons: a large-scale single-cell PCR study of the human caudate nucleus. Exp Gerontol 2002, 37:1389-1400.
34. Martinelli C., Sartori P., Ledda M., Pannese E. A study of mitochondria in spinal ganglion neurons during life: quantitative changes from youth to extremely advanced age. Tissue Cell 2006, 38:93-98.
35. Loewe L. Quantifying the genomic decay paradox due to Muller's ratchet in human mitochondrial DNA. Genet Res 2006, 87:133-159.
36. Loewe L., Cutter A.D. On the potential for extinction by Muller's ratchet in Caenorhabditis elegans. BMC Evol Biol 2008, 8:125.
37. Agnati FL, Guidolin D, Baluska F, Leo G, Barlow PW, Carone C, et al. A new hypothesis of pathogenesis based on the divorce between mitochondria and their host cells: possible relevances for the Alzheimer's disease. Curr Alzheimer Res 2009 Sep 28 [Epub ahead of print].
38. Fujita S. The discovery of the matrix cell, the identification of the multipotent neural stem cell and the development of the central nervous system. Cell Struct Funct 2003, 28:205-228.
39. Azevedeo F.A., Carvalho L.R., Ginberg L.T., Farfel J.M., Ferretti R.E., Leite R.E., et al. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J Comp Neurol 2009, 513:532-541.
40. Rajasimha H.K., Chinnery P.F., Samuels D.C. Selection against pathogenic mtDNA mutations in a stem cell population leads to the loss of the 3243A→G mutation in blood. Am J Hum Genet 2008, 82:333-343.
41. Taivassalo T., Fu K., Johns T., Arnold D., Karpati G., Shoubridge E.A. Gene shifting: a novel therapy for mitochondrial myopathy. Hum Mol Genet 1999, 8:1047-1052.
42. Guescini M, Genedani S, Stocchi V, Agnati LF. Astrocytes and Glioblastoma cells release exosomes carrying mtDNA. J Neural Transm 2009 Aug 13 [Epub ahead of print].
43. Cavanagh J.B., Nolan C.C., Brown A.W. Glial cell intrusions actively remove detritus due to toxic chemicals from within nerve cells. Neurotoxicology 1990, 11:1-12.
44. Schimper A.F.W. Über die Entwicklung der Chlorophyllkörner und Farbkörper. Bot Zeitung 1883, 41:105-112. 121-31, 137-46, 153-62.
45. Merezhkowsky C. Über Natur und Ursprung der Chromatophoren im Pflanzenreiche. Biol Zentralbl 1905, 25:593-604.
46. Wallin I.E. The mitochondria problem. The Am Nat 1923, 57:255-261.
47. de Grey A.D.N.J. Forces maintaining organellar genomes: is any as strong as genetic code disparity or hydrophobicity?. BioEssays 2005, 27:436-446.
48. Allen J.F. Control of gene expression by redox potential and the requirement for chloroplast and mitochondrial genomes. J Theoret Biol 1993, 165:609-631.
49. Allen J.F., Puthiyaveetil S., Ström J., Allen C.A. Energy transduction anchors genes in organelles. BioEssays 2005, 27:426-435.
50. Muller H.J. The relation of recombination to mutational advance. Mutat Res 1964, 1:2-9.
51. Dani S.U. The challenge of vector development in gene therapy. Braz J Med Biol Res 1999, 32:133-145.
52. D'Souza G.G., Weissig V. Approaches to mitochondrial gene therapy. Curr Gene Ther 2004, 4:317-328.
53. Khan S.M., Bennett J.P. Development of mitochondrial gene replacement therapy. J Bioenerg Biomembr 2004, 36:387-393.
54. D'Souza G.G., Boddapati S.V., Weissig V. Gene therapy of the other genome: the challenges of treating mitochondrial DNA defects. Pharm Res 2007, 24:228-238.
55. Doyle S.R., Chan C.K. Mitochondrial gene therapy: an evaluation of strategies for the treatment of mitochondrial DNA disorders. Hum Gene Ther 2008, 19:1335-1348.
56. Kyriakouli D.S., Boesch P., Taylor R.W., Lightowlers R.N. Progress and prospects: gene therapy for mitochondrial DNA disease. Gene Ther 2008, 15:1017-1023.
57. Yoneda M., Miyake T., Attardi G. Complementation of mutant and wild-type human mitochondrial DNAs coexisting since the mutation event and lack of complementation of DNAs introduced separately into a cell within distinct organelles. Mol Cell Biol 1994, 14:2699-2712.
58. Bacman S.R., Williams S.L., Hernandez D., Moraes C.T. Modulating mtDNA heteroplasmy by mitochondria-targeted restriction endonucleases in a 'differential multiple cleavage-site' model. Gene Ther 2007, 14:1309-1318.
59. Alexeyev M.F., Venediktova N., Pastukh V., Shokolenko I., Bonilla G., Wilson G.L. Selective elimination of mutant mitochondrial genomes as therapeutic strategy for the treatment of NARP and MILS syndromes. Gene Ther 2008, 15:516-523.
60. Agarwal A., Lariya N., Saraogi G., Dubey N., Agrawal H., Agrawal G.G. Nanoparticles as novel carrier for brain delivery: a review. Curr Pharm Des 2009, 15:917-925.
61. Constantinides P.P., Chaubal M.V., Shorr R. Advances in lipid nanodispersions for parenteral drug delivery and targeting. Adv Drug Deliv Rev 2008, 60:757-767.
62. Liguori L., Lenormand J.L. Production of recombinant proteoliposomes for therapeutic uses. Methods Enzymol 2009, 465:209-223.
63. Pathak A., Patnaik S., Gupta K.C. Recent trends in non-viral vector-mediated gene delivery. Biotechnol J 2009, 4:1559-1572.
64. Yamada Y., Akita H., Kogure K., Kamiya H., Harashima H. Mitochondrial drug delivery and mitochondrial disease therapy - an approach to liposome-based delivery targeted to mitochondria. Mitochondrion 2007, 7:63-71.
65. Yamada Y., Harashima H. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases. Adv Drug Deliv Rev 2008, 60:1439-1462.
66. Moreira P.I., Zhu X., Wang X., Lee H.G., Nunomura A., Petersen R.B., et al. Mitochondria: a therapeutic target in neurodegeneration. Biochim Biophys Acta 2010, 1802:212-220.
67. Nishimura I., Uetsuki T., Dani S.U., Ohsawa Y., Saito I., Okamura H., et al. Degeneration in vivo of rat hippocampal neurons by wild-type Alzheimer amyloid precursor protein overexpressed by adenovirus-mediated gene transfer. J Neurosci 1998, 18:2387-2398.
68. Dani S.U., Uetsuki T., Nishimura I., Saito I., Yoshikawa K. Improved adenovirus-mediated gene transfer to neurons in the brain: effect of intraparenchymal injection of hypertonic mannitol and concentration of the vector particles in the infuscate. Virus Rev Res 1998, 3:41-49.
69. Pottiez G., Flahaut C., Cecchelli R., Karamanos Y. Understanding the blood-brain barrier using gene and protein expression profiling technologies. Brain Res Rev 2009, 62:83-98.
70. Meirelles F.V., Bordignon V., Watanabe Y., Watanabe M., Dayan A., Lôbo R.B., et al. Complete replacement of the mitochondrial genotype in a Bos indicus calf reconstructed by nuclear transfer to a Bos taurus oocyte. Genetics 2001, 158:351-356.
71. Tachibana M., Sparman M., Sritanaudomchai H., Ma H., Clepper L., Woodward J., et al. Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature 2009, 461:367-372.
72. Fukami M.H., Salganicoff L. Isolation and properties of human platelet mitochondria. Blood 1973, 42:913-918.
73. Dani S.U., Gomes-Ruiz A.C., Dani M.A. Evaluation of a method for high yield purification of largely intact mitochondrial DNA from human placentae. Genet Mol Res 2003, 2:178-184.